share_log

Enliven Therapeutics | ARS: Annual Report to Security Holders

SEC ·  Apr 28, 2023 15:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more